raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:33067

Metaphyseal chondrodysplasia, Jansen type

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Infancy, Neonatal
Status
active

A rare autosomal dominant skeletal dysplasia characterized by short-limbed short stature (due to severe metaphyseal changes that are often discovered in childhood by imaging), waddling gait, bowed legs, contracture deformities of the joints, short hands with clubbed fingers, clinodactyly, prominent upper face and small mandible, as well as chronic parathyroid hormone-independent hypercalcemia, hypercalciuria, and mild hypophosphatemia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMetaphyseal chondrodysplasia, Jansen type
frChondrodysplasie métaphysaire type Jansen
deChondrodysplasie, metaphysäre, Typ Jansen
esCondrodisplasia metafisaria tipo Jansen
itCondrodisplasia metafisaria, tipo Jansen
nlMetafysaire chondrodysplasie, Jansen-type
ptCondrodisplasia metafisária tipo Jansen
plChondrodysplazja przynasadowa typu Jansena
csMetafyzární chondrodysplázie Jansen
ukМетафізарна хондродисплазія, тип Янсена
zh干骺端软骨发育不良,Jansen型
trMetafizeal kondrodisplazi, Jansen tipi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM156400Evalidated
ICD-10Q78.5NTBTattributedvalidated
ICD-11LD24.7NTBTindexvalidated
MONDO0007982Evalidated
MeSHC537564Evalidated
UMLSC0265295Evalidated
GARD79Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PTH1RDisease-causing germline mutation(s) (gain of function) inAssessedHGNC:9608ENSG000001608011684683p21.31parathyroid hormone 1 receptor7701349[PMID]_8703170[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families16 casesWorldwideCase(s)ValidatedORPHANET
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

25 annotations · validated 2025-01-08
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0006487Bowing of the long bones
HP:0008873Disproportionate short-limb short stature
HP:0003155Elevated circulating alkaline phosphatase concentration
HP:0000218High palate
HP:0003080Hydroxyprolinuria
HP:0003072Hypercalcemia
HP:0002150Hypercalciuria
HP:0000316Hypertelorism
HP:0002148Hypophosphatemia
HP:0000347Micrognathia
HP:0000938Osteopenia
HP:0002694Sclerosis of skull base
HP:0002753Thin bony cortex
HP:0002515Waddling gait
Occasional (29-5%)
HP:0200138Bilateral choanal atresia/stenosis
HP:0000494Downslanted palpebral fissures
HP:0008872Feeding difficulties in infancy
HP:0000293Full cheeks
HP:0034392Joint contracture
HP:0002643Neonatal respiratory distress
HP:0000121Nephrocalcinosis
HP:0000520Proptosis
HP:0000883Thin ribs
HP:0010537Wide cranial sutures
Excluded (0%)
HP:0003165Elevated circulating parathyroid hormone level

Annotation source: 20301736[PMID]_39086440[PMID]_29566257[PMID]

7

Sources for this card